Dartmouth-Hitchcock Health recorded a net loss of $150.3 million in the three months ended March 31. This compares to a net income of $46.9 million recorded in the same period in 2019.
The net loss included an operating loss of $59.3 million and nonoperating losses of more than $90.9 million.
Overall, the health system recorded revenue of $562.8 million in the third quarter of fiscal year 2020, down from the $569.4 million recorded in the third quarter of fiscal 2019.
Dartmouth said that it continued to experience growth in patient volume until the second week of March, due to the suspension of elective procedures. The health system said it incurred a revenue loss of $34.6 million in March.
Dartmouth also saw its expenses rise in the third quarter to $622.1 million, up from $567.4 million in the same quarter in fiscal 2019.
More articles on healthcare finance:
Mass General Brigham posts $1.6B loss in Q2
New York hospital lays off 70 after denial of federal funding
Hospitals blast CMS decision to double down on price transparency
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
